Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognosis of pN3 stage gastric cancer.
Ahn JR, Jung M, Kim C, Hong MH, Chon HJ, Kim HR, Jeung HC, Hyung WJ, Lee SS, Chung HC, Noh SH, Rha SY. Ahn JR, et al. Among authors: kim c, kim hr. Cancer Res Treat. 2009 Jun;41(2):73-9. doi: 10.4143/crt.2009.41.2.73. Epub 2009 Jun 30. Cancer Res Treat. 2009. PMID: 19707504 Free PMC article.
Clinical value of ezrin expression in primary osteosarcoma.
Kim C, Shin E, Hong S, Chon HJ, Kim HR, Ahn JR, Hong MH, Yang WI, Roh JK, Rha SY. Kim C, et al. Among authors: kim hr. Cancer Res Treat. 2009 Sep;41(3):138-44. doi: 10.4143/crt.2009.41.3.138. Epub 2009 Sep 28. Cancer Res Treat. 2009. PMID: 19809563 Free PMC article.
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.
Shin SJ, Ahn JB, Park KS, Lee YJ, Hong YS, Kim TW, Kim HR, Rha SY, Roh JK, Kim DH, Kim C, Chung HC. Shin SJ, et al. Among authors: kim tw, kim dh, kim c, kim hr. Invest New Drugs. 2012 Apr;30(2):672-80. doi: 10.1007/s10637-010-9625-x. Epub 2010 Dec 29. Invest New Drugs. 2012. PMID: 21188464 Clinical Trial.
A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy.
Shin SJ, Jung M, Jeung HC, Kim HR, Rha SY, Roh JK, Chung HC, Ahn JB. Shin SJ, et al. Among authors: kim hr. Invest New Drugs. 2012 Aug;30(4):1501-10. doi: 10.1007/s10637-011-9683-8. Epub 2011 May 13. Invest New Drugs. 2012. PMID: 21567184 Clinical Trial.
3,227 results